HRMY logo

HRMY Cash and cash equivalents

annual cash & cash equivalents:

$453.00M+$141.34M(+45.35%)
December 31, 2024

Summary

  • As of today (July 1, 2025), HRMY annual cash & cash equivalents is $453.00 million, with the most recent change of +$141.34 million (+45.35%) on December 31, 2024.
  • During the last 3 years, HRMY annual cash & cash equivalents has risen by +$218.69 million (+93.33%).
  • HRMY annual cash & cash equivalents is now at all-time high.

Performance

HRMY Cash and cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHRMYbalance sheet metrics

quarterly cash & cash equivalents:

$489.00M+$36.00M(+7.95%)
March 31, 2025

Summary

  • As of today (July 1, 2025), HRMY quarterly cash & cash equivalents is $489.00 million, with the most recent change of +$36.00 million (+7.95%) on March 31, 2025.
  • Over the past year, HRMY quarterly cash & cash equivalents has increased by +$156.02 million (+46.85%).
  • HRMY quarterly cash & cash equivalents is now at all-time high.

Performance

HRMY quarterly cash & cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHRMYbalance sheet metrics

Cash and cash equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

HRMY Cash and cash equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+45.4%+46.9%
3 y3 years+93.3%+117.8%
5 y5 years+1752.2%+583.8%

HRMY Cash and cash equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+93.3%at high+106.7%
5 y5-yearat high+1752.2%at high+541.1%
alltimeall timeat high+1752.2%at high+1899.4%

HRMY Cash and cash equivalents History

DateAnnualQuarterly
Mar 2025
-
$489.00M(+7.9%)
Dec 2024
$453.00M(+45.4%)
$453.00M(+16.9%)
Sep 2024
-
$387.37M(+22.1%)
Jun 2024
-
$317.30M(-4.7%)
Mar 2024
-
$332.98M(+6.8%)
Dec 2023
$311.66M(+27.8%)
$311.66M(-4.0%)
Sep 2023
-
$324.60M(+2.3%)
Jun 2023
-
$317.42M(+10.2%)
Mar 2023
-
$287.96M(+18.1%)
Dec 2022
$243.78M
$243.78M(-6.7%)
Sep 2022
-
$261.34M(+10.5%)
DateAnnualQuarterly
Jun 2022
-
$236.53M(+5.4%)
Mar 2022
-
$224.50M(-4.2%)
Dec 2021
$234.31M(+2.5%)
$234.31M(+23.5%)
Sep 2021
-
$189.70M(+18.8%)
Jun 2021
-
$159.69M(+13.1%)
Mar 2021
-
$141.17M(-38.3%)
Dec 2020
$228.63M(+834.8%)
$228.63M(+3.1%)
Sep 2020
-
$221.74M(+190.7%)
Jun 2020
-
$76.28M(+6.7%)
Mar 2020
-
$71.52M(+192.4%)
Dec 2019
$24.46M(-70.7%)
$24.46M
Dec 2018
$83.52M
-

FAQ

  • What is Harmony Biosciences Holdings annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Harmony Biosciences Holdings?
  • What is Harmony Biosciences Holdings annual cash & cash equivalents year-on-year change?
  • What is Harmony Biosciences Holdings quarterly cash & cash equivalents?
  • What is the all time high quarterly cash & cash equivalents for Harmony Biosciences Holdings?
  • What is Harmony Biosciences Holdings quarterly cash & cash equivalents year-on-year change?

What is Harmony Biosciences Holdings annual cash & cash equivalents?

The current annual cash & cash equivalents of HRMY is $453.00M

What is the all time high annual cash & cash equivalents for Harmony Biosciences Holdings?

Harmony Biosciences Holdings all-time high annual cash & cash equivalents is $453.00M

What is Harmony Biosciences Holdings annual cash & cash equivalents year-on-year change?

Over the past year, HRMY annual cash & cash equivalents has changed by +$141.34M (+45.35%)

What is Harmony Biosciences Holdings quarterly cash & cash equivalents?

The current quarterly cash & cash equivalents of HRMY is $489.00M

What is the all time high quarterly cash & cash equivalents for Harmony Biosciences Holdings?

Harmony Biosciences Holdings all-time high quarterly cash & cash equivalents is $489.00M

What is Harmony Biosciences Holdings quarterly cash & cash equivalents year-on-year change?

Over the past year, HRMY quarterly cash & cash equivalents has changed by +$156.02M (+46.85%)
On this page